Laura Shawver sold ARS Pharmaceuticals ($SPRY) shares once on the open market in the last year, for a total of $615 thousand. Her most recent sale occurred on April 7, 2025. These sales rank her 6,022nd among 11,678 insiders by value, well below the average of $8.6 million across 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 25, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| April 7, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 27493 | $0.00 | 24,062.0000 | 102,390,828 | 53.33% | 0.03% |
| April 7, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 22509 | $4.85 | 232,855.0000 | 102,390,828 | 10.70% | 0.02% |
| April 7, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 27493 | $4.85 | 260,348.0000 | 102,390,828 | 11.81% | 0.03% |
| April 7, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 50002 | $12.30 | 210,346.0000 | 102,390,828 | 19.21% | 0.05% |
| April 7, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 22509 | $0.00 | 51,555.0000 | 102,390,828 | 30.39% | 0.02% |
| March 5, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 400 | $0.00 | 123,664.0000 | 102,390,828 | 0.32% | 0.00% |
| March 5, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 400 | $4.85 | 210,746.0000 | 102,390,828 | 0.19% | 0.00% |
| March 5, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 400 | $11.00 | 210,346.0000 | 102,390,828 | 0.19% | 0.00% |
| March 6, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 49600 | $4.85 | 259,946.0000 | 102,390,828 | 23.58% | 0.05% |
| March 6, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 49600 | $11.21 | 210,346.0000 | 102,390,828 | 19.08% | 0.05% |
| March 6, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 49600 | $0.00 | 74,064.0000 | 102,390,828 | 40.11% | 0.05% |
| Feb. 3, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 9064 | $0.00 | 0.0000 | 102,390,828 | 100.00% | 0.01% |
| Feb. 3, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 9064 | $3.15 | 219,410.0000 | 102,390,828 | 4.31% | 0.01% |
| Feb. 3, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 40936 | $4.85 | 260,346.0000 | 102,390,828 | 18.66% | 0.04% |
| Feb. 3, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 50000 | $12.31 | 210,346.0000 | 102,390,828 | 19.21% | 0.05% |
| Feb. 3, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 40936 | $0.00 | 124,064.0000 | 102,390,828 | 24.81% | 0.04% |
| Jan. 6, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 50000 | $11.10 | 210,346.0000 | 102,390,828 | 19.21% | 0.05% |
| Jan. 6, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 50000 | $3.15 | 260,346.0000 | 102,390,828 | 23.77% | 0.05% |
| Jan. 6, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 50000 | $0.00 | 9,064.0000 | 102,390,828 | 84.65% | 0.05% |
| Dec. 3, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 62378 | $0.00 | 73,836.0000 | 97,032,331 | 45.79% | 0.06% |
| Dec. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 67616 | $1.27 | 277,962.0000 | 97,032,331 | 32.15% | 0.07% |
| Dec. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 29628 | $1.27 | 307,590.0000 | 97,032,331 | 10.66% | 0.03% |
| Dec. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 96343 | $13.55 | 211,247.0000 | 97,032,331 | 31.32% | 0.10% |
| Dec. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 901 | $14.34 | 210,346.0000 | 97,032,331 | 0.43% | 0.00% |
| Dec. 3, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 25606 | $1.27 | 235,952.0000 | 97,032,331 | 12.17% | 0.03% |
| Dec. 3, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 62378 | $3.15 | 298,330.0000 | 97,032,331 | 26.44% | 0.06% |
| Dec. 3, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 87984 | $13.26 | 210,346.0000 | 97,032,331 | 29.49% | 0.09% |
| Dec. 4, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Common Stock | 14772 | $3.15 | 225,118.0000 | 97,032,331 | 7.02% | 0.02% |
| Dec. 4, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | S | Common Stock | 14772 | $13.75 | 210,346.0000 | 97,032,331 | 6.56% | 0.02% |
| Dec. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 29628 | $0.00 | 25,606.0000 | 97,032,331 | 53.64% | 0.03% |
| Dec. 2, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 67616 | $0.00 | 0.0000 | 97,032,331 | 100.00% | 0.07% |
| Dec. 3, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 25606 | $0.00 | 0.0000 | 97,032,331 | 100.00% | 0.03% |
| Dec. 4, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | M | Stock Option (Right to Buy) | 14772 | $0.00 | 59,064.0000 | 97,032,331 | 20.01% | 0.02% |
| June 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 3, 2024 | Relay Therapeutics, Inc. | $RLAY | Shawver Laura | Not found | A | Stock Option (Right to Buy) | 102225 | $0.00 | 102,225.0000 | 0 | 9999.99% | 0.00% |
| Sept. 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 100000 | $7.71 | 210,346.0000 | 0 | 32.22% | 0.00% |
| Sept. 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 2997 | $1.27 | 213,343.0000 | 0 | 1.42% | 0.00% |
| Sept. 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 97003 | $1.27 | 310,346.0000 | 0 | 45.47% | 0.00% |
| Sept. 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 2997 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 97003 | $0.00 | 55,235.0000 | 0 | 63.72% | 0.00% |
| Aug. 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 26017 | $0.00 | 21,894.0000 | 0 | 54.30% | 0.00% |
| Aug. 4, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 18897 | $0.00 | 2,997.0000 | 0 | 86.31% | 0.00% |
| Aug. 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 26107 | $1.27 | 236,453.0000 | 0 | 12.41% | 0.00% |
| Aug. 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 26107 | $7.01 | 210,346.0000 | 0 | 11.04% | 0.00% |
| Aug. 4, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 18897 | $1.27 | 229,243.0000 | 0 | 8.98% | 0.00% |
| Aug. 4, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 18897 | $7.06 | 210,346.0000 | 0 | 8.24% | 0.00% |
| Aug. 2, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 36281 | $7.09 | 210,346.0000 | 0 | 14.71% | 0.00% |
| Aug. 2, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 36281 | $0.00 | 48,001.0000 | 0 | 43.05% | 0.00% |
| Aug. 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 18715 | $1.27 | 229,061.0000 | 0 | 8.90% | 0.00% |
| Aug. 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 18715 | $7.19 | 210,346.0000 | 0 | 8.17% | 0.00% |
| Aug. 2, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 36281 | $1.27 | 246,627.0000 | 0 | 17.25% | 0.00% |
| Aug. 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 18715 | $0.00 | 84,282.0000 | 0 | 18.17% | 0.00% |
| July 7, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 8858 | $1.27 | 219,204.0000 | 0 | 4.21% | 0.00% |
| July 7, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 8858 | $0.00 | 102,997.0000 | 0 | 7.92% | 0.00% |
| July 7, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 8858 | $6.36 | 210,346.0000 | 0 | 4.04% | 0.00% |
| July 5, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 31112 | $0.00 | 145,365.0000 | 0 | 17.63% | 0.00% |
| July 6, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 33510 | $0.00 | 111,855.0000 | 0 | 23.05% | 0.00% |
| July 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 26520 | $1.27 | 236,866.0000 | 0 | 12.61% | 0.00% |
| July 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 26520 | $6.73 | 210,346.0000 | 0 | 11.20% | 0.00% |
| July 5, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 31112 | $1.27 | 241,458.0000 | 0 | 14.79% | 0.00% |
| July 5, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 31112 | $6.41 | 210,346.0000 | 0 | 12.89% | 0.00% |
| July 6, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 33510 | $1.27 | 243,856.0000 | 0 | 15.93% | 0.00% |
| July 6, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 33510 | $6.34 | 210,346.0000 | 0 | 13.74% | 0.00% |
| July 3, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 26520 | $0.00 | 176,477.0000 | 0 | 13.06% | 0.00% |
| June 27, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| June 2, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 26941 | $6.95 | 210,346.0000 | 0 | 11.35% | 0.00% |
| June 2, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 26941 | $0.00 | 202,997.0000 | 0 | 11.72% | 0.00% |
| June 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 73059 | $1.27 | 283,405.0000 | 0 | 34.73% | 0.00% |
| June 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 73059 | $6.80 | 210,346.0000 | 0 | 25.78% | 0.00% |
| June 2, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 26941 | $1.27 | 237,287.0000 | 0 | 12.81% | 0.00% |
| June 1, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 73059 | $0.00 | 229,938.0000 | 0 | 24.11% | 0.00% |
| May 31, 2023 | Relay Therapeutics, Inc. | $RLAY | Shawver Laura | Director | A | Stock Option (Right to Buy) | 66055 | $0.00 | 66,055.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Relay Therapeutics, Inc. | $RLAY | Shawver Laura | Director | G | Common Stock | 12099 | $0.00 | 40,000.0000 | 0 | 23.22% | 0.00% |
| Nov. 9, 2022 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 43896 | $4.58 | 210,346.0000 | 0 | 17.27% | 0.00% |
| May 8, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 57100 | $1.27 | 267,446.0000 | 0 | 27.15% | 0.00% |
| May 8, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 57100 | $6.16 | 210,346.0000 | 0 | 21.35% | 0.00% |
| May 9, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Common Stock | 42900 | $1.27 | 253,246.0000 | 0 | 20.39% | 0.00% |
| May 9, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | S | Common Stock | 42900 | $5.31 | 210,346.0000 | 0 | 16.94% | 0.00% |
| May 9, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 42900 | $0.00 | 302,997.0000 | 0 | 12.40% | 0.00% |
| May 8, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shawver Laura | Director | M | Stock Option (Right to Buy) | 57100 | $0.00 | 345,897.0000 | 0 | 14.17% | 0.00% |